Abstract:Neuropsychiatric disorders are clinical conditions that affect cognitive function and emotional stability, often resulting from damage or disease in the central nervous system (CNS). These disorders are a worldwide concern, impacting approximately 12.5% of the global population. The gut microbiota has been linked to neurological development and function, implicating its involvement in neuropsychiatric conditions. Due to their interaction with gut microbial communities, probiotics offer a natural alternative to traditional treatments such as therapeutic drugs and interventions for alleviating neuropsychiatric symptoms. Introduced by Metchnikoff in the early 1900s, probiotics are live microorganisms that provide various health benefits, including improved digestion, enhanced sleep quality, and reduced mental problems. However, concerns about their safety, particularly in immunocompromised patients, warrant further investigation; this has led to the concept of "paraprobiotics", inactivated forms of beneficial microorganisms that offer a safer alternative. This review begins by exploring different methods of inactivation, each targeting specific cellular components like DNA or proteins. The choice of inactivation method is crucial, as the health benefits may vary depending on the conditions employed for inactivation. The subsequent sections focus on the potential mechanisms of action and specific applications of probiotics and paraprobiotics in neuropsychiatric therapy. Probiotics and paraprobiotics interact with gut microbes, modulating the gut microbial composition and alleviating gut dysbiosis. The resulting neuropsychiatric benefits primarily stem from the gut-brain axis, a bidirectional communication channel involving various pathways discussed in the review. While further research is needed, probiotics and paraprobiotics are promising therapeutic agents for the management of neuropsychiatric disorders.

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry

Targeting the Microbiota, From Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics

Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression

Brain-Gut-Microbiota Axis and Mental Health

Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis

Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health

The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients

Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials

From Probiotics to Psychobiotics: Live Beneficial Bacteria Which Act on the Brain-Gut Axis

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders

Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy

One Giant Leap from Mouse to Man: The Microbiota–Gut–Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials

Probiotics’ Effects in the Treatment of Anxiety and Depression: A Comprehensive Review of 2014–2023 Clinical Trials

Mind, Mood and Microbiota—Gut–Brain Axis in Psychiatric Disorders

The influence of the gut-brain axis on anxiety and depression: A review of the literature on the use of probiotics

The Gut-Brain-Microbiome Connection: Can Probiotics Decrease Anxiety and Depression?

Gut Biome and Mental Health: Do Probiotics Work?

Probiotics for the treatment of depression and its comorbidities: A systemic review

Approach of probiotics in mental health as a psychobiotics